Connection
Mark Clements to Remission Induction
This is a "connection" page, showing publications Mark Clements has written about Remission Induction.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.104 |
|
|
|
-
Forss A, Clements M, Myrelid P, Strid H, S?derman C, Wagner A, Andersson D, Hjelm F, Ol?n O, Halfvarson J, Ludvigsson JF. Ustekinumab Is Associated with Real-World Long-Term Effectiveness and Improved Health-Related Quality of Life in Crohn's Disease. Dig Dis Sci. 2023 01; 68(1):65-76.
Score: 0.054
-
Forss A, Clements M, Myrelid P, Strid H, S?derman C, Wagner A, Andersson D, Hjelm F, Ol?n O, Ludvigsson JF, Halfvarson J. Prospective observational study on Stelara (ustekinumab) assessing effectiveness in Crohn's disease (PROSE): a 16-week follow-up. Scand J Gastroenterol. 2021 Jun; 56(6):680-686.
Score: 0.050